A*STAR, Cytos Biotechnology provide update on Phase 1 clinical trial of H1N1 …
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on …
Read more on News-Medical.net
7 Biotechnology Stocks to Sell Now
The overall ratings of seven Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”). Genomic Health (NASDAQ:GHDX) is on the decline this week, earning a D (“sell”) after receiving …
Read more on Investorplace.com
Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI)
The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ listed securities that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology …
Read more on NASDAQ (press release)